Skip to main content
  • H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ, New York, May 20, 2024
    Michael Levitan, VP Investor Relations and Corporate Communications will present on Monday, May 20 at 09:30 EDT/15:30 CET.

For more information about this conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at or your H.C. Wainwright representative.

Cookies: This website uses cookies Check the cookies page for more information Accept Decline